- Country: Ukraine
- Summary: L-Lysine Escinate, Solution for Injection, 1 Mg/Ml, 5 Ml Each; Amiodarone, Solution for Injection, 50 Mg/Ml, 3 Ml Each; Chondroitin Sulfate Solution for Injection, 100 Mg/Ml in 2 Ml; Potassium Asparaginate/Magnesium Asparaginate...
- UAT Ref No: 128816437
- Deadline: 28 Oct 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: UAH 202194
- Notice Type: Tender
- Document Ref. No.: UA-2025-10-23-012302-a
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- L-lysine escinate, solution for injection, 1 mg/ml, 5 ml each; Amiodarone, solution for injection, 50 mg/ml, 3 ml each; Chondroitin sulfate solution for injection, 100 mg/ml in 2 ml; Potassium asparaginate/Magnesium asparaginate solution for injections of 5 ml; Hydrocortisone, suspension for injections, 25 mg/ml, 2 ml each; diphenhydramine, solution for injections, 10 mg/ml, 1 ml each; Drotaverin, solution for injection, 20 mg/ml, 2 ml each; Quercetin lyophilisate for solution for injection 0.5 g; Ambroxol solution for inhalation and oral use 7.5 mg/ml in 2 ml; Lidocaine, spray, 10%, 38 g each; Lidocaine, solution for injection, 20 mg/ml, 2 ml each; Lidocaine, solution for injection, 100 mg/ml, 2 ml each; Meloxicam solution for injections 10 mg/ml in 1.5 ml; Meropenem, powder for injections/infusions, 1 g each; Meldonium solution for injections, 100 mg/ml, 5 ml each; Metoclopramide, solution for injection, 5 mg/ml, 2 ml each; Nefopam, solution for injection, 10 mg/ml, 2 ml each; Procaine solution for injection 5 mg/ml in ampoule 5 ml; Norepinephrine, concentrate for solution for infusions, 2 mg/ml in 4 ml; Pyridoxine (vitamin B6), solution for injection, 50 mg/ml, 1 ml each; Neostigmine, solution for injection, 0.5 mg/ml, 1 ml each; Ethyl alcohol 96% 100 ml.; Ethyl alcohol 70% 100 ml.; Enoxaparin sodium, solution for injection, 10,000 anti-Xa IU/ml, 5.0 ml each; Urapidil solution for injection 5 mg/ml in 5 ml; Human insulin (short-acting), solution for injection, 100 U/ml, bottle, 10 ml; Cefazolin, powder for injections of 1 g; Cyanocobalamin (vitamin B12), dis...
View purchases: Goods
DK 021:2015:33600000-6: Pharmaceutical products
L-lysine escinate, solution for injection, 1 mg/ml, 5 ml each, Amiodarone, solution for injection, 50 mg/ml, 3 ml each, Chondroitin sulfate solution for injection, 100 mg/ml each 2 ml, Potassium asparaginate/Magnesium asparaginate solution for injection, 5 ml each, Hydrocortisone, suspension for injection, 25 mg/ml, 2 ml each... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINL-Lysine Escinate, Solution for Injection, 1 Mg/Ml, 5 Ml Each; Amiodarone, Solution for Injection, 50 Mg/Ml, 3 Ml Each; Chondroitin Sulfate Solution for Injection, 100 Mg/Ml in 2 Ml; Potassium Asparaginate/Magnesium Asparaginate... - Ukraine Tender
The MUNICIPAL NON-PROFIT ENTERPRISE "MYRNOGRAD CENTRAL CITY HOSPITAL" OF THE MYRNOGRAD CITY COUNCIL, a Government sector organization in Ukraine, has announced a new tender for L-Lysine Escinate, Solution for Injection, 1 Mg/Ml, 5 Ml Each; Amiodarone, Solution for Injection, 50 Mg/Ml, 3 Ml Each; Chondroitin Sulfate Solution for Injection, 100 Mg/Ml in 2 Ml; Potassium Asparaginate/Magnesium Asparaginate.... This tender is published on UkraineTenders under UAT Ref No: 128816437 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-10-28.
The estimated tender value is UAH 202194, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
